Elan, Electropharmacology Inc. deal

EPHI signed a letter of intent to acquire a worldwide license to ELN's iontophoretic patch technology for non-cosmetic dermatology and wound care applications. EPHI plans to develop a flexible patch version of its pulsed electromagnetic signal (PEMS) technology and a combination patch using iontophoresis and PEMS. EPHI will make an upfront payment to ELN and pay royalties and license fees based on future revenues. ...